帮忙改正英文语法我有中文原文及翻译软件给出的英文,希望英文高手能给我把语法改正过来,就是一些词语的顺序而已,因为时间很急

帮忙改正英文语法
我有中文原文及翻译软件给出的英文,希望英文高手能给我把语法改正过来,就是一些词语的顺序而已,因为时间很急,所以来求助了.
以下：
本章以“创新药物”研发链为背景,分析在新药研发各阶段中的风险以及企业管理上可应对的策略.新药研发项目的生命周期可分为4个阶段：（1）早期候选药物的筛选,包括先导化合物的产生和优化、体外药效模型和体内药效模型的建立、市场潜能评价等；（2）临床前研究,包括药理学、毒理学、药剂学和微生物学研究等；（3）临床试验,包括安全性、有效性、药代动力学研究等；（4）上市及营销监测.新药研发项目风险的成因很复杂,需要分别对上述新药研发过程中的每一个阶段进行分析,寻找该阶段可能遇到的不确定性因素以及该因素出现的概率和对研发项目的影响程度,并有针对性地采取应对策略,加强对风险的有效控制,进而减少、转移和分散新药研发项目的风险,以提高新药研发项目的成功率,增强制药企业的竞争力.
This chapter of "innovative drug" R & D chain,as the background,analyze the various stages of drug development and corporate risk management strategy can cope with.The life cycle of new drug R & D projects can be divided into four phases:(1) early screening of drug candidates,including the creation and optimization of lead compounds,in vitro and in vivo pharmacodynamic efficacy model model,the market potential evaluation; (2) pre-clinical studies,including pharmacology,toxicology,pharmacy and microbiology studies,etc.; (3) clinical trials,including safety,efficacy,pharmacokinetics studies,etc.; (4) listing and marketing surveillance.The causes of the risk of new drug R & D projects are complex and require each of these new drug R & D process in each stage of analysis,looking at that stage of uncertainty factors that may be encountered as well as the factors,the probability and the degree of influence on the R & D projects,and adopt coping strategies targeted to enhance the effective control of risk,thereby reducing the transfer and dispersion of the risk of new drug R & D projects to improve the success rate of new drug R & D projects to enhance the competitiveness of pharmaceutical companies.

Using "innovative drug" R & D chain as background,this chapter aim to analyze the risks in the different stages of new drugs development and the strategies that can cope with in corporate management.The life cycle of new drug R & D projects can be divided into four phases:(1) early screening of drugs,including the creation and optimization of lead compounds,in vitro and in vivo pharmacodynamic efficacy model model,the market potential evaluation; (2) pre-clinical studies,including pharmacology,toxicology,pharmacy and microbiology studies,etc.; (3) clinical trials,including safety,efficacy,pharmacokinetics studies,etc.; (4) listing and marketing control.The causes of the risk of new drug R & D projects are complex and analysis are needed for each of these new drug R & D process in each stage,in order to look for any uncertain factors that may be encountered in that stage,as well as the probability of these factors,and the degree of influence on the R & D projects.Strategies are adopted to enhance the effective control of risk,thereby reducing the transfer and dispersion of the risk of new drug R & D projects to improve the success rate of new drug R & D projects and enhance the competitiveness of pharmaceutical companies.
专门的词不会翻,参考了翻译软件给出的英文.最后一句「新药研发项目风险……企业的竞争力」太长,分开来说比较清楚.
希望能够帮助你!